RecruitingNot ApplicableNCT05750901
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
Pilot Evaluation of Fractional Ablative Laser Treatment for Skin Laxity and Tightening
Sponsor
Sciton
Enrollment
1,000 participants
Start Date
Nov 1, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
Evaluate the safety and efficacy of the fractional ablative laser for treatment of skin laxity and tightening
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Fractional ablative laser for people with skin laxity. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 85 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEFractional ablative laser
Fractional ablative laser used for treatment for skin laxity and tightening
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05750901
Related Trials
PLLA-LASYNPRO™ Injections for Skin Laxity Treatment
NCT076371881 location
A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
NCT073990281 location
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
NCT072248801 location
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
NCT069416101 location
Effects of QUANTUM Probe for Skin Rejuvenation and Subdermal Retraction in Patients Undergoing High-Definition Liposculpture
NCT069589781 location